Salvage Combination Therapies for Refractory Overactive Bladder-Reference-Cited by-同舟云学术

Salvage Combination Therapies for Refractory Overactive Bladder

Published:2018-11-12 Issue:4 Volume:13 Page:301-308
ISSN:1931-7212
Container-title:Current Bladder Dysfunction Reports
language:en
Short-container-title:Curr Bladder Dysfunct Rep

Author:

Martin Sarah,Han Esther,Gilleran Jason

Publisher

Springer Science and Business Media LLC

Subject

Molecular Biology,Biochemistry

Link

http://link.springer.com/article/10.1007/s11884-018-0496-x/fulltext.html

Reference64 articles.

1. Leron E, Weintraub AY, Mastrolia SA, Schwarzman P. Overactive bladder syndrome: evaluation and management. Curr Urol. 2017;11:117–25 Available at: https://www.karger.com/Article/FullText/447205 . Accessed 1 July 2018.

2. Coyne KS, Wein A, Nicholson S, Kvasz M, Chen CI, Milsom I. Economic burden of urgency urinary incontinence in the United States: a systematic review. J Manag Care Pharm. 2014;20:130–40. Available at: http://www.jmcp.org/doi/10.18553/jmcp.2014.20.2.130 . Accessed 7 June 2018.

3. Ganz ML, Smalarz AM, Krupski TL, et al. Economic costs of overactive bladder in the United States. Urol. 2010;75:526–532.e18 Available at: http://linkinghub.elsevier.com/retrieve/pii/S0090429509023115 . Accessed 1 July 2018.

4. •• Gormley EA, Lightner DJ, Burgio KL, et al. Diagnosis and treatment of overactive bladder (non-neurogenic) in adults: AUA/SUFU Guideline. J Urol. 2012;188:2455–2463. Available at: http://linkinghub.elsevier.com/retrieve/pii/S0022534712049592 . Accessed 13 Aug 2018. Current guideline for OAB treatment.

5. •• Apostolidis A, Averbeck MA, Sahai A, et al. Can we create a valid treatment algorithm for patients with drug resistant overactive bladder (OAB) syndrome or detrusor overactivity (DO)? Results from a think tank (ICI-RS 2015). Neurourol Urodyn. 2017;36:882–893. Available at: https://onlinelibrary.wiley.com/doi/abs/10.1002/nau.23170 . Accessed 8 Apr 2018. First attempt to create a treatment algorithm for patients with OAB. It discusses AM failures, combination pharmacologic therapy, Botox vs neuromodulation, and augmentation cyoplasty—all of which is discussed in this review article.

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Update on Management of Overactive Bladder;Current Surgery Reports;2023-08-03

2. Botox rechallenge—An additional tool in the management of an incompletely emptying bladder and inadequate overactive symptom control following sacral neuromodulation;LUTS: Lower Urinary Tract Symptoms;2020-06-16